167 related articles for article (PubMed ID: 8167564)
1. B-CLL in PLL transformation associated with hypercalcemia.
Lerner D; Esteves C; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):321-5. PubMed ID: 8167564
[TBL] [Abstract][Full Text] [Related]
2. [B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report].
Muraoka A; Asami M; Ueno H; Yoneda R; Ogura M; Oribe T; Suzuki K; Maeda M; Chinzei T; Yamashiro K
Rinsho Ketsueki; 1990 Nov; 31(11):1840-4. PubMed ID: 2287070
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone-related protein (PTH-rP)-associated hypercalcemia in a patient with an atypical chronic lymphocytic leukemia.
Vlasveld LT; Pauwels P; Ermens AA; Aarnoudse WH; Ooms HW; Haak HR
Neth J Med; 1999 Jan; 54(1):21-6. PubMed ID: 10048292
[TBL] [Abstract][Full Text] [Related]
5. Involvement of central nervous system in prolymphocytoid transformation of chronic lymphocytic leukemia.
Kuwabara H; Kanamori H; Takasaki H; Takabayashi M; Yamaji S; Tomita N; Fujimaki K; Fujisawa S; Ishigatsubo Y
Leuk Lymphoma; 2003 Jul; 44(7):1235-7. PubMed ID: 12916878
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis.
Kimura A; Hyodo H; Nakata Y; Kuramoto A
Am J Hematol; 1993 May; 43(1):47-50. PubMed ID: 8317461
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotype of chronic lymphocytic leukemia and prolymphocytic leukemia].
Maruyama S
Nihon Rinsho; 1992 Jun; 50(6):1236-40. PubMed ID: 1518139
[TBL] [Abstract][Full Text] [Related]
8. [A case of B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)].
Ando S; Ando S; Otani N; Kanbe T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):153-6. PubMed ID: 8422181
[TBL] [Abstract][Full Text] [Related]
9. Management of chronic lymphocytic leukaemia.
Kalil N; Cheson BD
Drugs Aging; 2000 Jan; 16(1):9-27. PubMed ID: 10733261
[TBL] [Abstract][Full Text] [Related]
10. Prolymphocytic leukemia: diagnosis and treatment. A case report.
Akin C; Hansen P; Janckila A
J Ky Med Assoc; 1997 Nov; 95(11):465-7. PubMed ID: 9392933
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
Tumakov VA; Abdulkadyrov KM; Rugal' VI; Karpenkov MV; Ved' VV; Brodovskiĭ AF
Klin Med (Mosk); 1991 Jan; 69(1):94-7. PubMed ID: 2023411
[TBL] [Abstract][Full Text] [Related]
12. A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol).
Ferrara F; Del Vecchio L; Mele G; Rametta V; Ronconi F; Montuori R
Cancer; 1989 Aug; 64(4):789-92. PubMed ID: 2743271
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
14. Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
Witzig TE; Weitz JJ; Lundberg JH; Tefferi A
Leuk Lymphoma; 1994 Jun; 14(1-2):137-9. PubMed ID: 7920220
[TBL] [Abstract][Full Text] [Related]
15. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course.
Shvidel L; Shtalrid M; Bassous L; Klepfish A; Vorst E; Berrebi A
Leuk Lymphoma; 1999 Mar; 33(1-2):169-79. PubMed ID: 10194135
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
17. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
18. Prolymphocytic leukemia.
Stone RM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy.
Narayan H; Bandyopadhyay D; Schmidt K; Chachlani N; Hughes M; Paneesha S; Rose P; Borg A
Clin Lab Haematol; 2005 Dec; 27(6):405-8. PubMed ID: 16307545
[TBL] [Abstract][Full Text] [Related]
20. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
